GSK using CIIE to advance hepatitis B treatment in China
As China’s healthcare and policy environment continues to improve, global pharmaceutical company GlaxoSmithKline (GSK) is using the China International Import Expo (CIIE) to advance innovation in public health, enabling more people living with hepatitis B in China to benefit from its breakthroughs in prevention and treatment. “We look forward to tapping into the spillover effects…








